Leader in microbiology innovation

Please log in for more information

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the Retina field I want to stay up to date with the Infectious Diseases field I want to stay up to date with the Pathologist Educator field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

QuantaMatrix Europe
Villejuif Bio Park
1 Mail du Professeur Georges Mathé
94800 Villejuif, France

[email protected]

QuantaMatrix was founded in 2010 as an ivd company by Dr. Sunghoon Kwon, professor at Seoul National University in Korea. Our mission is to treat sepsis & antibiotics misuse by providing optimal antimicrobial prescription with our dRASTTM platform.

Minimizing time to optimal treatment is directly linked to patient survival., dRASTTM decreases the time to result by 30-50 hours. By reducing exposure to broad-spectrum treatment with dRASTTM, more optimal treatment against bacterial infection is available sooner and prevent antimicrobial resistance. Shortened treatment time helps reducing global healthcare cost with shorter length of stay in hospital.

Our goal is to continue to innovate in microbiology, molecular biology, and immunoassay.

Pillar Biosciences’ oncoReveal™ CDx Pan-Cancer Solid Tumor IVD: A Rapid FDA Approved NGS Kit to Help Drive Actionable and Accessible Localized Testing.

10/23/2024 | Sponsored by Illumina